ZYNERBA PHARMACEUTICALS INC (ZYNE) Stock Cash Flow
NASDAQ:ZYNE - Nasdaq - US98986X1090 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -37.58M | -35.04M | -37.31M | -51.34M | -32.94M | |||
| Depreciation Amortization | 221.88K | 219.28K | 247.14K | 210.00K | 130.00K | |||
| Change In Working Capital | 2.06M | 7.46M | -2.21M | 4.64M | -7.57M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 60.00K | |||
| Other non cash items | 3.65M | 4.33M | 5.81M | 5.18M | 5.56M | |||
| OPERATING CASH FLOW | -31.64M | -23.03M | -33.46M | -41.31M | -34.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -200.45K | -154.11K | -47.57K | -450.00K | -130.00K | |||
| INVESTING CASH FLOW | -200.45K | -154.11K | -47.57K | -450.00K | -130.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 5.73M | 6.56M | 43.24M | 31.71M | 45.38M | |||
| Other Financing Activity | -406.95K | -543.24K | -1.09M | -850.00K | -130.00K | |||
| FINANCING CASH FLOW | 5.32M | 6.01M | 42.16M | 30.85M | 45.25M | |||
| CHANGE IN CASH | -26.52M | -17.17M | 8.65M | -10.91M | 10.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.64M | -23.03M | -33.46M | -41.31M | -34.82M | |||
| Capital Expenditure | -200.45K | -154.11K | -47.57K | -450.00K | -130.00K | |||
| FREE CASH FLOW | -31.84M | -23.18M | -33.51M | -41.76M | -34.95M | |||
All data in USD